The advent of multidrug-resistant bacteria has drawn attention to the need for innovative antimicrobials to treat life-threatening infections. The current study investigates the in-silico design and synthesis of new quercetin derivatives in order to synthesise potent antibacterial and anti-inflammatory medicines. A naturally occurring flavonoid called quercetin has demonstrated encouraging therapeutic potential against microbial infections and inflammatory conditions